Summary
Bone infection has long been a formidable foe of orthopaedic surgeons. The standard method of treating osteomyelitis generally consists of irrigation and debridement supplemented by pre- and postoperative antibiotics and intraoperative antimicrobial solutions. In the 1970s, Buchholz introduced the concept of local antibacterial therapy in the form of antibiotic impregnated bone cement to treated infected arthroplasties. From this, antibiotic impregnated beads were developed to treat local infections of bone and soft tissue. The advantage of these beads compared with parenteral therapy is that they deliver a high concentration of antibacterial locally while avoiding high systemic concentrations, thus avoiding adverse effects that are often associated with parenteral antibacterial therapy.
Additionally, methylmethacrylate bone cement does not significantly affect the immune response of the body. This makes the use of antibiotic-impregnated polymethylmethacrylate (PMMA) beads highly effective either as an alternative to, or in conjunction with, systemic antibiotic treatment of infected arthroplasties, and localised bone and soft tissue infection. This article explores the indications for the use of local therapy as well as any advantages or disadvantages it may have over systemic antibacterial treatment. Additionally, there are important pharmacokinetic considerations for the optimal use of antibacterial agents in the treatment of osteomyelitis.
Similar content being viewed by others
References
Burri C. Post-traumatic osteomyelitis. Burn: Hans Huber, 1975: 11–7
Brady LP, Enneking WF, Franco JA. The effect of operating room environment on the infection rate after Charnley low-fraction total hip replacement. J Bone Joint Surg Am 1975; 57A: 80–3
Charnley J. The long-term results of low friction arthroplasty of the hip performed as primary intervention. J Bone Joint Surg Br 1972; 54B: 61–7
Coventry MB, Beckenbaugh RD, Nolan DR, et al. 2,021 total hip arthroplasties: a study of postoperative course and early complications. J Bone Joint Surg Am 1974; 56A: 273–84
Eftekhar N. Charnley ‘low-friction torque’ arthroplasty. Clin Orthop 1971; 81: 93–104
Nelson CE, Evarts CM, Andrish J, et al. Infected total hip replacement result and complications. In: Proceedings of the American Academy of Orthopaedic Surgeons. J Bone Joint Surg Am 1975; 57A: 1025
Salvati EA, Callaghan JJ, Brause BD, et al. Reimplantation in infection: elution of gentamicin from cement and beads. Clin Orthop 1986; 207: 83–93
Buchholz HW, Engelbrecht E. Über die Depotwirkung einiger Antibiotika bei Vermischung mit dem Kunstharz Palacos. Chirurgie 1970; 41: 511–3
Danzinger LH. Controversies in antimicrobial therapy: innovative methods of administration. Am J Pharm 1986; 43: 650–2
Marr M, Alozozzibe G. Use of tobramycin bone cement. Drug Intell Clin Pharm 1984; 18: 883–4
Von Fraunhofer JA, Polk HC, Seligson D. Leaching of tobramycin from PMMA bone cement beads. J Biomed Mater Res 1985; 19: 751–6
Harke A, Ritzerfeld W. The release of gentamicin into wound secretions from polymethylmethacrylate beads. Arch Orthop Trauma Surg 1979; 95: 65–70
Klemm K. Treatment of chronic bone infection with gentamicin-PMMA chains and beads. Accid Surg 1976; 1 (Spec. Is.): 20
Goodell JA, Flick AB, Herbert JC, et al. Preparation and release characteristics of tobramycin-impregnated poly-methylmethacrylate beads. Am J Hosp Pharm 1986; 43: 1454–61
Barton RPE, Moir AA. Use of a local gentamicin preparation (garamycin: chains) as prophylaxis against infection in major head or neck surgery: a pilot study. Pharmatherapeutica 1983; 3: 327–30
Aubry DA, Jenkins NJ, Morgan WP, et al. The use of gentamicin-PMMA chains in abdominal surgery: a pilot study of prophylaxis against wound infection. Pharmatherapeutica 1986; 4: 536–40
Kupferburg A, Zer M, Rabinson S. The use of PMMA beads in recurrent high anal fistula: a preliminary report. World Surg 1984; 8: 970–4
Spence RAJ, Anderson JR, Parks TG. The use of gentamicin-PMMA chains in colorectal surgery. Br J Clin Pract 1984; 38: 252–4
VecSci V. Long term results in the treatment of septic bone and soft tissue diseases with gentamicin-PMMA chains and beads. In: Van Rens TJG, Kayser FH, editors. Local antibiotic treatment in osteomyelitis and soft tissue infections. International Congress Series. Amsterdam: Excerpta Medica, 1981; 556: 50–9
Josefsson G, Lindberg L, Wiklander B. Systemic antibiotics and gentamicin-containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. Clin Orthop 1981; 159: 194–200
Carlsson AS, Lidgren L, Lindberg L. Prophylactic antibiotics against early and late deep infections after total hip replacements. Acta Orthop Scand 1977; 48: 405
Trippel SB. Antibiotic-impregnated cement in total joint arthroplasty. J Bone Joint Surg Am 1986; 68A: 1297–302
Walenkamp GHIM. Gentamicin-PMMA beads: a clinical, phar-macokinetic, and topological study. Darmstadt: E. Merck, 1983
Seligson, D. Anabiotic-impregnated beads in orthopaedic infectious problems. KY Med Assoc 1984; 82 Jan: 25–9
Marr M, Alozozzihe G. Use of tobramycin bone cement. Drug Intell Clin Pharm 1984; 18: 883–4
Voorhoeve A, Sohr C. Ergebnisse bei der Behandlung der chronisch-eitrigen Osteomyelitis mit einem Palacos-Gentamycin-Gemisch. Munch Med Wochenschr 1973; 115: 924–30
Scott DM, Rotschaf er JC, Behrens F. Use of vancomycin and tobramycin polymethylmethacrylate impregnated beads in the management of chronic osteomyelitis. Drug Intell Clin Pharm 1988; 22 Jun: 480–3
Soto-Hall R, Saenz L, Tavemetti R, et al. Tobramycin in bone cement: an in depth analysis of wound, serum, and urine concentrations in patients undergoing total hip revision arthroplasty. Clin Orthop 1983; 175: 60–4
Wahlig H, Dingeldein E. Antibiotics and bone cements: experimental and clinical long-term observations. Acta Orthop Scand 1980; 51: 49–56
Hoff SF, Fitzgerald RH, Kelly PJ. The depot administration of penicillin G and gentamicin in acrylic bone cement. J Bone Joint Surg Am 1981; 63A: 798–804
Dingeldein E, Bergmann R, Wahlig H, et al. Pharmacokinetics and tolerance of gentamicin poly methyl methacrylate beads in beagle dogs. Biomaterials 1980: 315–20
Pollock AV. Topical antibiotics. In Polk Jr HC, editor. Infection and the surgical patient. Edinburgh: Churchill Livingstone, 1982
Dingeldein E, Wahlig H. Freisetzung von Gentamycin aus Kunststoffkugeln während der Behandlung chronischer Knocheninfektionen [abstract no. 8]. VII. Kongress über dringliche Medizinische Hilfe, Prague; 1976: 17
Wahlig H, Dingeldein E, Bergmann R, et al. The release of gentamicin from polymethylmethacrylate beads. J Bone Joint Surg Br 1978; 60B: 270–5
Torholm C, Lidgren L. Lindberg L, et al. Total hip joint arthroplasty with gentamicin impregnated cement. Clin Orthop 1983; 181: 99–106
Petty W. Influence of methylmethacrylate on quantitative gel diffusion assay of immunoglobins. J Biomed Mater Res 1979; 13: 645–56
Panush RS, Petty W. Inhibition of human lymphocyte responses by methylmethacrylate. Clin Orthop 1978; 134: 356
Petty W. The effect of methylmethacrylate on chemotaxis of polymorphonuclear leukocytes. J Bone Joint Surg Am 1978; 60A: 492–8
Petty W. The effect of methylmethacrylate on bacterial phagocytosis and killing by human polymorphonuclear leukocytes. J Bone Joint Surg Am 1978; 60A: 752–7
Petty W. The effect of methylmethacrylate on the bacterial inhibiting properties of normal human serum. Clin Orthop 1978; 132: 266–78
Petty W, Caldwell JR. The effect of methylmethacrylate on complement activity. Clin Orthop 1977; 128: 354–60
Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 1962; 115: 453–66
Hurley JV. Substances promoting leucocyte emigration. Ann NY Acad Sci 1964; 116: 918–35
Hurley JV, Spector WG. Endogenous factors responsible for leucocyte emigration in vivo. J Pathol Bacteriol 1961; 82: 403–20
Keller HU, Sorkin E. Studies on chemotaxis: I. On the chemotic and complement-fixing activity of globulins. Immunology 1965; 9: 241–7
Keller HU, Sorkin E. Studies on chemotaxis: IV. The influence of serum factors of granulocyte locomotion. Immunology 1966; 10: 409–16
Keller HU, Sorkin E. Studies on chemotaxis: V. On the chemotactic effect of bacteria. Int Arch Allergy Immunol 1967; 31: 505–17
Leber TH. Über die Entstehung der Entzundung und die Wirkung der entzundungserregeden Schädlichkeiten. Fortschr Med 1988; 6: 460–4
Wilkinson PC, Borel JF, Stecher-Levin VJ, et al. Macrophage and neutrophil specific chemotactic factors in serum. Nature 1969; 222: 244–7
Convery FR, Gunn DR, Hughes JD, et al. The relative safety of polymethylmethacrylate. J Bone Joint Surg Am 1975; 57A: 57–64
McLaughlin RE, DiFazio CA, Hakala M, et al. Blood clearance and acute pulmonary toxicity of methylmethacrylate in dogs after simulated arthroplasty and intravenous injection. J Bone Joint Surg Am 1973; 55A: 1621–8
Modig J, Busch C, Olerud S. The importance of intravascular coagulation, fat embolism, and acrylic monomer for respiratory and circulatory dysfunctions during intramedullary endoprosthetic surgery. Proceedings of the Orthopaedic Research Society. J Bone Joint Surg Am 1975; 57A: 583
Feith R. Side effects of acrylic cement implanted into bone. Nijmegen: Drukkerij Brakkenstein, 1975
Linder L. Tissue reaction to methylmethacrylate monomer. Acta Orthop Scand 1976; 47: 3–10
Linder L, Romanus M. Acute local tissue effects of polymerizing acrylic bone cement. Clin Orthop 1976; 58A: 358
Slooff TJJH. The influence of acrylic cement. Acta Orthop Scand 1971; 42: 465–81
Henry SL, Popham GJ, Mangino P, et al. Antibiotic impregnated beads: a production technique. Contemp Orthop 1989; 19(3): 221–6
Sande MA, Mandell GC. The aminoglycoside (antimicrobial agents). In: Gilman AG, Goodman LS, Gilman A, editors. The pharmacologic basis of therapeutics. New York: Macmillan, 1980: 1174–5
Flick AB, Herbert JC, Goodell J, et al. Noncommercial fabrication of antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop 1987; 223: 282–6
Kirkpatrick DK, Trachtenberg LS, Mangino PD, et al. In vitro characteristics of tobramycin PMMA beads: compressive strength and leaching. Orthopaedics 1985; 8(9): 1130–3
Henry SL, Seligson D, Mangino P, et al. Antibiotic impregnated beads. Part I: bead implantation versus systemic therapy. Orthop Rev 1991; 20(3): 242–7
Rosin H, Rosin AM, Kramer J. Determination of antibiotic levels in human bone: I. Gentamicin levels in bone. Infection 1974; 2: 3
Rodeheaver GT, Rukstalis D, Bono M, et al. A new model of bone infection used to evaluate the efficacy of antibiotic-impregnated polymethylmethacrylate cement. Clin Orthop 1983; 178: 303–11
Buchholz HW, Elson RA, Englebrecht E, et al. Management of deep infection of total hip replacement. J Bone Joint Surg Br 1981; 63B: 342–3
Wahlig H, Dingeldein E, Buchholz HW, et al. Pharmacokinetic study of gentamicin-loaded cement in total hip replacements: comparative effects of varying dosage. J Bone Joint Surg Br 1984; 66B: 175–9
Marks KE, Nelson CL, Lautenschlager EP. Antibiotic impregnated acrylic bone cement. J Bone Joint Surg Am 1976; 58A: 358–64
Bayston R, Milner RDG. The sustained release of antimicrobial drugs from bone cement. J Bone Joint Surg Br 1982; 64B: 460–4
Elson RA, Jephcott AE, McGechie DB, et al. Bacterial infection and acrylic cement in the rat. J Bone Joint Surg Br 1977; 59B: 452–7
Chapman MW, Hadley WK. The effect of polymethylmethacrylate and antibiotic combinations on bacterial viability. J Bone Joint Surg Am 1976; 58A: 76–81
Levin PD. The effectiveness of various antibiotics in methylmethacrylate. J Bone Joint Surg Br 1975; 57B: 234–7
Calhoun JH, Mader JT. Antibiotic beads in the management of surgical infections. Am J Surg 1989; 457: 443–9
Kahlmeter G. Gentamicin and tobramycin, clinical pharmacokinetics and nephrotoxicity: aspects on assay techniques. Scand J Infect Dis 1979; 18 Suppl.: 12–22
Bayston R, Milner RDG. The sustained release characteristics of antimicrobial drugs from bone cement. J Bone Joint Surg Br 1982; 64B: 460–4
Elson RA, Jephcott AE, McGechie DB, et al. Bacterial infection and acrylic cement in the rat. J Bone Joint Surg Br 1977; 59B: 452–7
Law HT, Fleming RH, McCarthy ID, et al. The mechanism of diffusion of antibiotic through acrylic bone cements. J Bone Joint Surg Br 1987; 69B: 497
VecSei V, Barquet A. Treatment of chronic osteomyelitis by necrotomy and gentamicin PMMA beads. Clin Orthop 1981; 159: 201–7
Cierny III G, Mader IT, Penninck JJ. A clinical staging system for adult osteomyelitis. Contemp Orthop 1985; 10(5): 17–37
Law HT, Fleming RH, Gilmore MP, et al. In vitro measurement and computer modeling of the diffusion of antibiotic in bone cement. J Biomed Eng 1986; 8(2): 149–55
Bunetel L, Segui A, Cormier M, et al. Comparative study of gentamicin release from normal and low viscosity acrylic bone cement. Clin Pharmacokinet 1990; 19: 333–40
Preston DA, Wick WE. Preclinical assessment of the antibacterial activity of nebramycin factor G. Antimicrob Agents Chemother 1970; annual: 322–7
Ristuccia AM, Cuhna BA. The aminoglycosides. Med Clin North Am 1982; 66(1): 303–12
Watanakunakorn C. Penicillin combined with gentamicin and streptomycin: synergism against enterococci. Infect Dis 1971; 124: 581–6
Weinstein AJ, Moellering RC. Penicillin and gentamicin therapy for enterococcal infections. JAMA 1973; 223: 1030–2
Picknell B, Mizen L, Sutherland R, et al. Antibacterial activity of antibiotics in acrylic bone cement. J Bone Joint Surg Br 1977; 59 Suppl.: 302–7
Lawson KJ, Marks KE, Brems J, et al. Vancomycin vs tobramycin elution from polymethylmethacrylate: an in vitro study. Orthopaedics 1990; 13(5): 521–4
Born-again vancomycin [editorial]. Lancet 1985; 1: 677–8
Van Rens TJG, Kayser FH, editors. Local antibiotic treatment in osteomyelitis and soft tissue infections. Amsterdam: Excerpta Medica, 1981
Eckman Jr JB, Henry SL, Mangino PD, et al. Wound and serum levels of tobramycin with the prophylactic use of tobramycin-impregnated polymethylmethacrylate beads in compound fractures. Clin Orthop 1988; 237: 213–5
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Henry, S.L., Galloway, K.P. Local Antibacterial Therapy for the Management of Orthopaedic Infections. Clin-Pharmacokinet 29, 36–45 (1995). https://doi.org/10.2165/00003088-199529010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199529010-00005